The GNE Gene Nonaka Myopathy Genetic Test is a specialized diagnostic examination available at DNA Labs UAE, aimed at identifying mutations in the GNE gene, which are associated with Nonaka Myopathy, also known as GNE Myopathy or Distal Myopathy with Rimmed Vacuoles (DMRV). Nonaka Myopathy is a rare genetic disorder characterized by progressive muscle weakness and wasting, primarily affecting the lower limbs before spreading to other parts of the body. Early and accurate detection through this genetic test can be crucial for the management and treatment of the condition.
The test is priced at 4400 AED and involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the state-of-the-art facilities at DNA Labs UAE. The laboratory employs advanced genetic sequencing techniques to scrutinize the GNE gene for any mutations that might indicate the presence of Nonaka Myopathy. This test is essential for individuals with a family history of the disease or those exhibiting symptoms, as it can provide a definitive diagnosis, facilitating timely interventions and genetic counseling.
DNA Labs UAE is renowned for its commitment to accuracy, confidentiality, and support throughout the testing process, making it a trusted choice for genetic testing services in the region.
The NDP Gene Norrie Disease Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the NDP gene, which are responsible for Norrie disease. This rare genetic disorder primarily affects the eyes, leading to severe visual impairment or blindness from birth or early infancy. It may also cause progressive hearing loss and, in some cases, developmental delays or mental health issues. By analyzing the specific genetic markers associated with Norrie disease, this test can provide essential information for accurate diagnosis, enabling timely intervention and management strategies. The cost of the NDP Gene Norrie Disease Genetic Test at DNA Labs UAE is 4400 AED, reflecting the comprehensive analysis and the sophisticated technology employed to ensure precise results.
Occipital Horn Syndrome (OHS) is a rare connective tissue disorder that is considered a mild form of Menkes disease, which primarily affects copper levels in the body. This condition is linked to mutations in the ATP7A gene. The ATP7A gene plays a crucial role in regulating the body's copper balance, which is vital for brain development, nervous system function, and the health of connective tissues. Mutations in this gene can lead to copper deficiency, which manifests in symptoms associated with OHS, including distinctive facial features, connective tissue abnormalities, and skeletal malformations.
To diagnose OHS, a genetic test targeting the ATP7A gene can be conducted. DNA Labs UAE offers this specific test, providing a reliable method for diagnosing OHS by identifying mutations in the ATP7A gene. The test is particularly useful for confirming the diagnosis in patients showing symptoms of the disorder, as well as for carrier testing in family members of affected individuals.
The cost of the ATP7A Gene Occipital Horn Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This test is a critical step towards a definitive diagnosis, enabling healthcare providers to offer appropriate management and treatment options for individuals with OHS. It also offers families the opportunity for genetic counseling, which can be essential in understanding the condition and in planning for future children.
The MID1 Gene Opitz G/BBB Syndrome Genetic Test is a specialized diagnostic tool used to identify mutations in the MID1 gene, which are associated with Opitz G/BBB Syndrome. This condition is a genetic disorder characterized by a wide spectrum of symptoms, including developmental delays, distinctive facial features, and abnormalities in the midline of the body such as cleft lip or palate, heart defects, and genitourinary anomalies. The test aims to provide definitive genetic evidence for the syndrome, aiding in the diagnosis and allowing for targeted management and genetic counseling for affected families.
Performed at DNA Labs UAE, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific mutations in the MID1 gene. The cost of the test is 4400 AED, reflecting the comprehensive analysis and the specialized expertise required to interpret the results. Given the complexity of genetic disorders, this test is a crucial step in understanding the specific mutations that contribute to Opitz G/BBB Syndrome, enabling personalized treatment plans and supporting families in managing the condition.
The OFD1 Gene Oral-Facial-Digital Syndrome Type 1 Genetic Test is a specialized diagnostic tool designed to identify mutations in the OFD1 gene, which are associated with Oral-Facial-Digital Syndrome Type 1 (OFD1). This rare genetic disorder is characterized by a wide range of physical anomalies affecting the oral cavity, facial features, and digits. Symptoms may include abnormalities in the teeth, tongue, and lips, cleft palate, facial asymmetry, as well as malformations of the fingers and toes.
Performed at DNA Labs UAE, this test involves analyzing the patient's DNA to detect mutations in the OFD1 gene that are indicative of the syndrome. The process is aimed at individuals who exhibit symptoms of OFD1, as well as family members of those diagnosed with the condition, to assess their risk of carrying the gene mutation.
The cost of the OFD1 Gene Oral-Facial-Digital Syndrome Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This price includes the collection of a DNA sample, usually through a blood draw or cheek swab, and the subsequent genetic analysis. The results from this test can provide valuable information for diagnosis, guiding treatment options, and offering insight into the inheritance pattern of the syndrome within families. It is a critical step towards personalized care and management of the condition, helping affected individuals and their families to understand their genetic makeup and its implications on their health.
The PANK2 gene pantothenate kinase-associated neurodegeneration genetic test is a specialized diagnostic procedure aimed at identifying mutations in the PANK2 gene, which are associated with a rare, inherited neurological disorder known as pantothenate kinase-associated neurodegeneration (PKAN). PKAN is characterized by a variety of symptoms including dystonia, spasticity, and neurodegeneration, and it typically manifests in childhood or early adolescence.
This genetic test involves analyzing the patient's DNA to detect mutations in the PANK2 gene that are linked to the development of PKAN. The process is crucial for confirming a diagnosis of PKAN, which can then guide treatment and management strategies for affected individuals.
The test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the PANK2 gene pantothenate kinase-associated neurodegeneration genetic test at DNA Labs UAE is 4400 AED. Opting for this test at DNA Labs UAE ensures that patients receive accurate and reliable results, thanks to the lab's use of state-of-the-art technology and adherence to high standards of genetic analysis.
The SCN4A gene paramyotonia congenita of von Eulenburg genetic test is a specialized diagnostic examination aimed at identifying mutations in the SCN4A gene, which are responsible for the rare neuromuscular disorder known as paramyotonia congenita of von Eulenburg. This condition is characterized by episodes of muscle stiffness triggered by cold temperatures or prolonged muscle use, and it is inherited in an autosomal dominant pattern. The test is crucial for confirming the diagnosis, enabling appropriate management and genetic counseling for affected individuals and their families.
Conducted at DNA Labs UAE, this genetic test involves analyzing the patient's DNA to detect specific mutations in the SCN4A gene that are linked to the disorder. The process requires a sample of the patient's blood or saliva, from which DNA is extracted and examined for the presence of these mutations.
The cost of the SCN4A gene paramyotonia congenita of von Eulenburg genetic test at DNA Labs UAE is 4400 AED. This price reflects the specialized nature of the test, which includes the costs of laboratory procedures, analysis by genetic experts, and the provision of a comprehensive report detailing the findings. For patients and families affected by paramyotonia congenita of von Eulenburg, this test is a valuable tool for understanding their condition and making informed decisions about their health care and lifestyle.
The "ALX4 Gene Parietal Foramina Type 2 Genetic Test" is a specialized diagnostic procedure designed to identify mutations in the ALX4 gene, which are associated with the development of Parietal Foramina Type 2, a rare genetic condition. This condition is characterized by the incomplete closure of the skull bones, specifically at the parietal bones, leading to foramina, or gaps, which can vary in size. These gaps are typically symptomless but can be associated with other cranial or neurological abnormalities in some cases.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test is crucial for individuals with a family history of Parietal Foramina or related symptoms. It provides essential genetic insights that can aid in the accurate diagnosis, management, and understanding of the condition's inheritance patterns. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for specific mutations in the ALX4 gene that are indicative of Parietal Foramina Type 2.
The cost of the ALX4 Gene Parietal Foramina Type 2 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, including the advanced genetic sequencing and analysis required to detect mutations accurately. While the cost may seem significant, the value of the information it provides for affected individuals and their families can be invaluable, offering insights that facilitate informed medical and personal decisions regarding the condition.
The SNCA Gene PARK1 Parkinson Genetic Test is a specialized diagnostic tool used to detect mutations in the SNCA gene, which are strongly associated with the development of Parkinson's disease. Parkinson's disease is a progressive neurological disorder characterized by tremors, stiffness, and difficulty with balance and coordination. The SNCA gene plays a crucial role in the production of alpha-synuclein, a protein that, when mutated, can lead to the formation of abnormal protein deposits in the brain, a hallmark of Parkinson's disease.
This genetic test is particularly important for individuals with a family history of Parkinson's disease or those showing early symptoms, as it can provide valuable information regarding their risk of developing the condition. Early detection through genetic testing can enable proactive management of the disease, potentially improving quality of life.
The test is available at DNA Labs UAE, a leading facility in genetic diagnostics and research. DNA Labs UAE utilizes state-of-the-art technology to ensure accurate and reliable results. The cost of the SNCA Gene PARK1 Parkinson Genetic Test is 4400 AED, reflecting the comprehensive analysis and expertise required to interpret the results. By choosing to undergo this test at DNA Labs UAE, individuals gain access to crucial genetic information that can inform their healthcare decisions and potentially lead to early intervention strategies for Parkinson's disease.
The HTRA2 Gene PARK13 Parkinson Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the HTRA2 gene, which have been associated with the development of Parkinson's disease. This test is particularly significant for individuals with a family history of Parkinson's disease or those exhibiting early symptoms, as it provides crucial genetic information that can aid in the early diagnosis and management of this neurodegenerative disorder.
Parkinson's disease is a progressive neurological condition characterized by tremors, stiffness, and difficulty with balance and coordination. The HTRA2 gene, also known as PARK13, plays a vital role in mitochondrial function and the regulation of cell death, with mutations in this gene linked to increased susceptibility to Parkinson's disease. By analyzing the genetic makeup of the HTRA2 gene, the test can identify specific mutations that may increase an individual's risk of developing Parkinson's disease.
Conducted at the state-of-the-art facilities of DNA Labs UAE, the test is priced at 4400 AED. The process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of mutations in the HTRA2 gene. Results from the test can provide valuable insights into an individual's risk of developing Parkinson's disease, enabling healthcare providers to tailor early intervention strategies and potentially improve patient outcomes.
The HTRA2 Gene PARK13 Parkinson Genetic Test is an important resource for individuals seeking to understand their genetic risk for Parkinson's disease and for healthcare professionals aiming to provide targeted care for their patients.
